Published in Circulation on August 01, 1994
Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology (2008) 2.14
Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors. J Clin Invest (1996) 1.57
Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems. PLoS One (2015) 1.40
K(ATP) channel therapeutics at the bedside. J Mol Cell Cardiol (2005) 1.27
Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Heart (2004) 1.09
The emerging chondrocyte channelome. Front Physiol (2010) 1.08
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes Care (2010) 1.08
Preconditioning the diabetic human myocardium. J Cell Mol Med (2009) 1.01
K+ channel opening: a new drug principle in cardiovascular medicine. Heart (1996) 0.92
Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci (2010) 0.92
Nitrite as a mediator of ischemic preconditioning and cytoprotection. Nitric Oxide (2011) 0.88
Subcellular mechanisms of adaptation in the diabetic myocardium: Relevance to ischemic preconditioning in the nondiseased heart. Exp Clin Cardiol (2010) 0.88
Antiarrhythmic and anti-ischaemic effects of angina in patients with and without coronary collaterals. Heart (2002) 0.87
Hyperglycemia and perioperative glucose management. Curr Pharm Des (2012) 0.87
Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection. Biochem J (1998) 0.85
ATP-sensitive potassium (K(ATP)) channel openers diazoxide and nicorandil lower intraocular pressure in vivo. Invest Ophthalmol Vis Sci (2013) 0.84
Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning. Basic Res Cardiol (1997) 0.83
Therapeutic potential of ischaemic preconditioning. Br J Clin Pharmacol (2000) 0.82
Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels. Cardiovasc Drugs Ther (1995) 0.81
The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus. Cardiovasc Diabetol (2009) 0.80
Does a selective adenosine A(1) receptor agonist protect against exercise induced ischaemia in patients with coronary artery disease? Heart (2002) 0.79
Pharmacological modulation of the ATP sensitive potassium channels during repeated coronary occlusions: no effect on myocardial ischaemia or function. Heart (2004) 0.79
Impact of hypoglycemic agents on myocardial ischemic preconditioning. World J Diabetes (2014) 0.79
Warm up phenomenon and preconditioning in clinical practice. Heart (2002) 0.79
The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes. Br J Pharmacol (1999) 0.78
Adenosine and ischemic preconditioning. Curr Pharm Des (1999) 0.77
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies. Cardiovasc Diabetol (2016) 0.77
Preconditioning the human heart. Ann R Coll Surg Engl (1997) 0.76
Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol (1997) 0.76
ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway. PLoS One (2017) 0.75
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease. Medicine (Baltimore) (2015) 0.75
Cardiovascular effects of anti-diabetes drugs. Expert Opin Drug Saf (2016) 0.75
Ischaemic preconditioning and myocardial adaptation to serial intracoronary balloon inflation: cut from the same cloth? Heart (2004) 0.75
Effect of different doses of noradrenaline against ischemia-induced ventricular arrhythmias in rat heart in vivo. Indian Pacing Electrophysiol J (2009) 0.75
Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer? Heart (2005) 0.75
Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction. Mayo Clin Proc (2009) 0.75
Regulation of ion channels in myocardial cells and protection of ischemic myocardium. Heart Fail Rev (2000) 0.75
Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence. Trends Endocrinol Metab (2017) 0.75
A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med (1997) 2.57
Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol (1991) 2.16
Use of the radial artery for myocardial revascularization. Ann Thorac Surg (1996) 1.94
Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med (1990) 1.89
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J Am Coll Cardiol (1989) 1.76
Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. Pacing Clin Electrophysiol (1993) 1.68
Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris. J Am Coll Cardiol (1991) 1.66
EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart (2008) 1.63
A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc (2000) 1.58
Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of alpha-adrenergic receptors in ischemic preconditioning. Circulation (1997) 1.53
Platelet aggregability in cardiac syndrome X. Eur Heart J (2001) 1.52
Mechanisms of the warm-up phenomenon. Eur Heart J (1996) 1.52
Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol (1998) 1.51
Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg (1987) 1.51
Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X) J Am Coll Cardiol (1991) 1.49
Aneurysm of the membranous ventricular septum. Surgical consideration and experience in 29 cases. J Thorac Cardiovasc Surg (1976) 1.46
Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris. Am J Cardiol (1991) 1.45
Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications. Eur Heart J (2001) 1.45
Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J (1996) 1.45
Clinical evaluation of St Jude Medical Hemodynamic Plus versus standard aortic valve prostheses: The Italian multicenter, prospective, randomized study. J Thorac Cardiovasc Surg (2001) 1.43
Restoration of atrioventricular conduction after surgical removal of a hydatid cyst of the interventricular septum. J Thorac Cardiovasc Surg (1987) 1.42
Very early prediction of restenosis after successful coronary angioplasty: anatomic and functional assessment. J Am Coll Cardiol (1990) 1.41
Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute myocardial infarction. Am Heart J (1993) 1.39
Levels of troponin I and cardiac enzymes after reinfusion of shed blood in coronary operations. Ann Thorac Surg (1998) 1.37
Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation (1998) 1.36
Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol (1999) 1.33
Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart (2002) 1.31
Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol (1996) 1.29
Cardiac echinococcosis causing coronary artery disease. Ann Thorac Surg (1999) 1.23
Effects of K(ATP) channel blockade by glibenclamide on the warm-up phenomenon. Eur Heart J (1999) 1.22
Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation (1986) 1.21
Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart (2003) 1.20
Laser recanalization of occluded atherosclerotic arteries in vivo and in vitro. Circulation (1985) 1.19
Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol (1999) 1.19
Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients. J Thorac Cardiovasc Surg (2008) 1.14
The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale. Compr Psychiatry (1991) 1.13
Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation (1997) 1.11
Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation (1999) 1.09
alpha-Adrenergic receptors and coronary spasm: an elusive link. Circulation (1984) 1.08
Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris. Am J Cardiol (1985) 1.07
Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation (2001) 1.07
Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol (1989) 1.05
Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol (1998) 1.04
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus. Atherosclerosis (2011) 1.02
Left ventricular pseudoaneurysm and mitral valve regurgitation. Conservative surgical therapy. J Cardiovasc Surg (Torino) (1999) 1.01
Opening and closing characteristics of the aortic valve after valve-sparing procedures using a new aortic root conduit. Ann Thorac Surg (2001) 1.01
Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease. Eur J Cardiol (1979) 1.01
Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe? Heart (2004) 1.00
Acute thrombosis of the sinus node artery: arrhythmological implications. Heart (2003) 0.99
Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. J Am Coll Cardiol (1998) 0.99
Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X. Heart (2009) 0.99
Reactivity of eccentric and concentric coronary stenoses in patients with chronic stable angina. J Am Coll Cardiol (1991) 0.99
Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation (1995) 0.98
The fate of ribosomal genes in three interspecific somatic hybrids of Medicago sativa: three different outcomes including the rapid amplification of new spacer-length variants. Theor Appl Genet (1996) 0.98
Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial. Am Heart J (1984) 0.97
Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol (1993) 0.95
Bentall procedure with a stentless valve and a new aortic root prosthesis. Ann Thorac Surg (2001) 0.95
Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications. Circulation (1994) 0.94
Correction of pectus excavatum with a self-retaining seagull wing prosthesis. Long-term follow-up. Chest (1995) 0.94
Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. Am J Physiol Heart Circ Physiol (2000) 0.93
Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris, and in acute myocardial infarction. Am J Cardiol (1995) 0.93
Intraoperative transesophageal echocardiography for pulmonary embolectomy without cardiopulmonary bypass. Ann Thorac Surg (1991) 0.93